473 related articles for article (PubMed ID: 16403519)
1. The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein.
Zhou W; Zhu M; Wilson MA; Petsko GA; Fink AL
J Mol Biol; 2006 Mar; 356(4):1036-48. PubMed ID: 16403519
[TBL] [Abstract][Full Text] [Related]
2. DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation.
Shendelman S; Jonason A; Martinat C; Leete T; Abeliovich A
PLoS Biol; 2004 Nov; 2(11):e362. PubMed ID: 15502874
[TBL] [Abstract][Full Text] [Related]
3. Destabilization of DJ-1 by familial substitution and oxidative modifications: implications for Parkinson's disease.
Hulleman JD; Mirzaei H; Guigard E; Taylor KL; Ray SS; Kay CM; Regnier FE; Rochet JC
Biochemistry; 2007 May; 46(19):5776-89. PubMed ID: 17451229
[TBL] [Abstract][Full Text] [Related]
4. DJ-1 modulates alpha-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70.
Batelli S; Albani D; Rametta R; Polito L; Prato F; Pesaresi M; Negro A; Forloni G
PLoS One; 2008 Apr; 3(4):e1884. PubMed ID: 18382667
[TBL] [Abstract][Full Text] [Related]
5. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Sharma N; Rao SP; Kalivendi SV
Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
[TBL] [Abstract][Full Text] [Related]
6. Effect of single amino acid substitution on oxidative modifications of the Parkinson's disease-related protein, DJ-1.
Madian AG; Hindupur J; Hulleman JD; Diaz-Maldonado N; Mishra VR; Guigard E; Kay CM; Rochet JC; Regnier FE
Mol Cell Proteomics; 2012 Feb; 11(2):M111.010892. PubMed ID: 22104028
[TBL] [Abstract][Full Text] [Related]
7. DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease.
Zondler L; Miller-Fleming L; Repici M; Gonçalves S; Tenreiro S; Rosado-Ramos R; Betzer C; Straatman KR; Jensen PH; Giorgini F; Outeiro TF
Cell Death Dis; 2014 Jul; 5(7):e1350. PubMed ID: 25058424
[TBL] [Abstract][Full Text] [Related]
8. Partially oxidized DJ-1 inhibits α-synuclein nucleation and remodels mature α-synuclein fibrils in vitro.
Kumar R; Kumar S; Hanpude P; Singh AK; Johari T; Majumder S; Maiti TK
Commun Biol; 2019; 2():395. PubMed ID: 31701024
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of DJ-1 neuroprotection in a cellular model of Parkinson's disease.
Liu F; Nguyen JL; Hulleman JD; Li L; Rochet JC
J Neurochem; 2008 Jun; 105(6):2435-53. PubMed ID: 18331584
[TBL] [Abstract][Full Text] [Related]
10. The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis.
Xu J; Zhong N; Wang H; Elias JE; Kim CY; Woldman I; Pifl C; Gygi SP; Geula C; Yankner BA
Hum Mol Genet; 2005 May; 14(9):1231-41. PubMed ID: 15790595
[TBL] [Abstract][Full Text] [Related]
11. DJ-1, a Parkinson's disease related protein, aggregates under denaturing conditions and co-aggregates with α-synuclein through hydrophobic interaction.
Zhu M; H Patel S; Han S
Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1759-1769. PubMed ID: 28330770
[TBL] [Abstract][Full Text] [Related]
12. DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity.
Zhou W; Freed CR
J Biol Chem; 2005 Dec; 280(52):43150-8. PubMed ID: 16227205
[TBL] [Abstract][Full Text] [Related]
13. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress.
Moore DJ; Zhang L; Troncoso J; Lee MK; Hattori N; Mizuno Y; Dawson TM; Dawson VL
Hum Mol Genet; 2005 Jan; 14(1):71-84. PubMed ID: 15525661
[TBL] [Abstract][Full Text] [Related]
14. Engineered disulfide bonds restore chaperone-like function of DJ-1 mutants linked to familial Parkinson's disease.
Logan T; Clark L; Ray SS
Biochemistry; 2010 Jul; 49(27):5624-33. PubMed ID: 20527929
[TBL] [Abstract][Full Text] [Related]
15. Reduced anti-oxidative stress activities of DJ-1 mutants found in Parkinson's disease patients.
Takahashi-Niki K; Niki T; Taira T; Iguchi-Ariga SM; Ariga H
Biochem Biophys Res Commun; 2004 Jul; 320(2):389-97. PubMed ID: 15219840
[TBL] [Abstract][Full Text] [Related]
16. Separation of native and C106-oxidized DJ-1 proteins by using column chromatography.
Choi J; Yoo HJ; Cho K; Kim HN; Lee JH; Ryu KS
Protein Expr Purif; 2022 Aug; 195-196():106092. PubMed ID: 35430350
[TBL] [Abstract][Full Text] [Related]
17. Use of cysteine-reactive cross-linkers to probe conformational flexibility of human DJ-1 demonstrates that Glu18 mutations are dimers.
Prahlad J; Hauser DN; Milkovic NM; Cookson MR; Wilson MA
J Neurochem; 2014 Sep; 130(6):839-53. PubMed ID: 24832775
[TBL] [Abstract][Full Text] [Related]
18. Formation of a stabilized cysteine sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1.
Blackinton J; Lakshminarasimhan M; Thomas KJ; Ahmad R; Greggio E; Raza AS; Cookson MR; Wilson MA
J Biol Chem; 2009 Mar; 284(10):6476-85. PubMed ID: 19124468
[TBL] [Abstract][Full Text] [Related]
19. Crystal structures of human DJ-1 and Escherichia coli Hsp31, which share an evolutionarily conserved domain.
Lee SJ; Kim SJ; Kim IK; Ko J; Jeong CS; Kim GH; Park C; Kang SO; Suh PG; Lee HS; Cha SS
J Biol Chem; 2003 Nov; 278(45):44552-9. PubMed ID: 12939276
[TBL] [Abstract][Full Text] [Related]
20. α-Synuclein is a pathological link and therapeutic target for Parkinson's disease and traumatic brain injury.
Shahaduzzaman M; Acosta S; Bickford PC; Borlongan CV
Med Hypotheses; 2013 Oct; 81(4):675-80. PubMed ID: 23920272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
